Jobs / United States / Gilead Sciences INC
Director, Drug Delivery System Strategy & Planning.
Gilead Sciences INC · 🇺🇸 United States - California - Foster City
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Gilead Sciences INC paid sponsored hires in similar roles1 certified filing for “Sr Director, Commercial Product Strategy” (Marketing Managers) in CA: $272k–$272k, median $272k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Gilead Sciences INC
The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Gilead Sciences INC →
About the role
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. Job Description The Director will serve an important role in developing, networking, and executing global strategies that expand and advance the company's ability to deliver robust, competitive technologies in drug delivery and combination products across Gilead’s pharmaceutical asset pipeline and portfolio. This role will serve as a critical bridge between Drug Delivery and Commercial, Medical, and Pharmaceutical Development & Manufacturing (PDM) and related strategy teams. Using strong business acumen and foundational technical expertise, the successful candidate will work collaboratively with cross-functional product teams to identify drug delivery system options and help shape the product system strategy. The candidate will also work across organizational boundaries to identify opportunities for differentiated product-system solutions and develop business cases to help drive strategic investment decisions in the most promising solutions. Through this multi-faceted role, this individual will help to ensure a seamless continuum from commercial strategy to the front-end innovation pipeline, and on to product development and commercialization. Specific Job Responsibilities • As a member of the Devices, Packaging, & Process (DPP) organization, contribute to building strategic thought partnerships across Commercial, Marketing, Medical, Global Value & Access, Program Strategy Teams, the broader DPP organization, and other PDM functions to influence program strategy decisions and advance holistic, competitive product-system solutions. • Serve as the DPP representative on early-stage (pre-pivotal) PDM programs. In this role, advise on and shape product system strategy and Target Product Profile (TPP) development, ensuring early product system decisions are grounded in patient, market, technical and execution considerations. • While this position has no direct reports, you will lead teams of scientists, engineers and project managers through dotted lines, to lead scenario planning and business case development for PDM and Gilead Asset Team decision-making, translating technical, commercial, user, and operational inputs into clear product system options and recommendations. • Monitor the development pipeline and maintain an evolving product roadmap and forecast for DPP across therapeutic areas, linking near-term asset needs with long-term innovation and launch readiness. • Monitor commercial launches, lifecycle management needs, competitive intelligence, and market/user preference research to generate insights and inform product system strategy and recommendations for PDM program teams and the Device